Testing of ketoprofen for interaction with oral antidiabetics. a double-blind controlled clinical crossover study
Voigt, U.; Klassen, E.
Die Medizinische Welt 33(45): 1592-1593
1982
ISSN/ISBN: 0025-8512 PMID: 6757642 Document Number: 194780
Document emailed within 1 workday
Related Documents
Clerico, M.; Bertetto, O.; Morandini, M.P.; Cardinali, C.; Giaccone, G. 1993: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design Tumori 79(2): 119-122Goldzieher, J.W.; Moses, L.E.; Averkin, E.; Scheel, C.; Taber, B.Z. 1971: A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives Fertility and Sterility 22(9): 609-623
Mehlisch, D.R. 1990: Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea Clinical Therapeutics 12(5): 398-409
Matucci-Cerinic, M.; Casini, A. 1988: Ketoprofen vs etofenamate in a controlled double-blind study: evidence of topical effectiveness in soft tissue rheumatic pain International Journal of Clinical Pharmacology Research 8(3): 157-160
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
De Buck, R.; Van Durme, R.; Pelc, I. 1975: A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders Acta Psychiatrica Belgica 75(3): 320-333
Langrick, A.F.; Gunn, A.D.; Livesey, H.; Whitehead, A.M. 1989: A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea British Journal of Clinical Practice 43(9): 317-321
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Moldofsky, H.; Lue, F.A.; Mously, C.; Roth-Schechter, B.; Reynolds, W.J. 1996: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study Journal of Rheumatology 23(3): 529-533
Horak, F.; Matthes, H. 1982: The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study Annals of Allergy 48(5): 305-308
Gulias-Herrero, A.; Aguilar-Salinas, C.A.; Gómez-Pérez, F.J.; Rull, J.A. 2003: The combination metformin/glyburide exerts its hypoglycemic effect mainly by increasing insulin secretion: a controlled, randomized, double-blind, crossover study Diabetes Nutrition and Metabolism 16(5-6): 268-276
Franke, W.; Bachert, C.; Messinger, D. 1989: Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge Arzneimittel-Forschung 39(10a): 1354-1356
Brügmann, U.; Blasini, R.; Rudolph, W. 1983: Anti-ischemic effect of nifedipine in delayed-action form. Results of a double-blind, randomized, crossover, placebo-controlled acute study Herz 8(4): 206-210
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Fauvel, J.P.; Najem, R.; Maakel, N.; Pozet, N.; Laville, M. 1998: Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study Journal of Cardiovascular Pharmacology 32(3): 495-499
Dougados, M.; Caporal, R.; Doury, P.; Thiesce, A.; Pattin, S.; Laffez, B.; Amor, B. 1989: A double blind crossover placebo controlled trial of ximoprofen in as Journal of Rheumatology 16(8): 1167-1169
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Soonthornpun, S.; Rattarasarn, C.; Thamprasit, A.; Leetanaporn, K. 1998: Effect of acarbose in treatment of type Ii diabetes mellitus: a double-blind, crossover, placebo-controlled trial Journal of the Medical Association of Thailand 81(3): 195-200
Young, S.A.; Hurt, P.H.; Benedek, D.M.; Howard, R.S. 1998: Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial Journal of Clinical Psychiatry 59(2): 76-80
Bhettay, E.; Thomson, A.J. 1978: Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis South African Medical Journal 54(7): 276-278